Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)

Annals of Hematology

Volumn 91, Issue 5, 2012, Pages 743-749

  Sivgin, Serdar ^a   Eser, Bulent ^a   Bahcebasi, Sami ^a   Kaynar, Leylagul ^a   Kurnaz, Fatih ^a   Uzer, Elmas ^a   Pala, Cigdem ^a   Deniz, Kemal ^a   Ozturk, Ahmet ^a   Cetin, Mustafa ^a   Unal, Ali ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Allogeneic hematopoietic stem cell transplantation (alloHSCT); Deferasirox; Iron chelation; Iron overload; Liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; BUSULFAN; COTRIMOXAZOLE; CYCLOSPORIN; CYCLOSPORIN A; CYTARABINE; DEFERASIROX; FLUCONAZOLE; FLUDARABINE; METHOTREXATE; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; VALACICLOVIR; BENZOIC ACID DERIVATIVE; IRON CHELATING AGENT; TRIAZOLE DERIVATIVE;

ABDOMINAL DISCOMFORT; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; KIDNEY FUNCTION TEST; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; MYCOSIS; NAUSEA; PHLEBOTOMY; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; VIRUS INFECTION; VOMITING; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IRON OVERLOAD; KIDNEY; LEUKEMIA; LIVER; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; BENZOIC ACIDS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; KIDNEY; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LIVER; MALE; MIDDLE AGED; PHLEBOTOMY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSPLANTATION, HOMOLOGOUS; TRIAZOLES; YOUNG ADULT;

EID: 84861444296     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1358-1     Document Type: Article

References (34)

1. Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M (2009) Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15:195-204
2. Alt'es A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E (2002) Iron overload might increase transplant-related mortality in haemotopoietic stem cell transplantation. Bone Marrow Transplant 29:987-989 (Pubitemid 34845954)
3. Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199-211 (Pubitemid 40040559)
4. Evens AM, Mehta J, Gordon LI (2004) Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 34:561-571 (Pubitemid 39341534)
5. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, Di Gregorio F, Burattini MG, Terzoli S (1989) Survival and causes of death in thalassaemia major. Lancet 2 (8653):27-30 (Pubitemid 19158169)
6. Rahav G, Volach V, Shapiro M, Rund D, Rachmilewitz EA, Goldfarb A (2006) Severe infections in thalassaemic patients: prevalence and predisposing factors. Br J Haematol 133:667-674 (Pubitemid 43742785)
7. McKay PJ, Murphy JA, Cameron S, Burnett AK, Campbell M, Tansey P, Franklin IM (1996) Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 17:63-68
8. Beutler E, Hoffbrand AV, Cook JD (2003) Hematology iron deficiency and overload. Hematology Am Soc Hematol Educ Program 40-61
9. Sucak GT, Yegin ZA, Ozkurt ZN, Aki SN, Karakan T, Akyol G (2008) The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? Bone Marrow Transplant 42:461-467
10. Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS (2009) Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 44(12):793-797
11. Majhail NS, DeFor T, Lazarus HM, Burns LJ (2008) High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 14:790-794 (Pubitemid 351773155)
12. Joachim Deeg H, Spaulding E, Shulman HM (2009) Iron overload, hematopoietic cell transplantation, and graft-versushost disease. Leuk Lymphoma 50:1566-1572
13. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI (2003) Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102:2670-2677 (Pubitemid 37193611)
14. Parkkinen J, Sahlstedt L, von Bonsdorff L, Salo H, Ebeling F, Ruutu T (2006) Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 135:228-234 (Pubitemid 44401621)
15. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH (2007) Prognostic impact of elevated pretransplant serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:4586-4588 (Pubitemid 46743431)
16. Altès A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E (2002) Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 12:987-989 (Pubitemid 34845954)
17. Ozyilmaz E, Aydogdu M, Sucak G, Aki SZ, Ozkurt ZN, Yegin ZA, Kokturk N (2010) Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplant 45:1528-1533
18. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42:799-805
19. Maertens J, Demuynck H, Verbeken EK, Zachée P, Verhoef GE, Vandenberghe P, Boogaerts MA (1999) Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 24:307-312 (Pubitemid 29377872)
20. de Witte T (2008) The role of iron in patients after bone marrow transplantation. Blood Rev 22(Suppl 2):22-28
21. Altes A, Remacha AF, Sarda P, Baiget M, Sureda A, Martino R, Briones J, Brunet S, Canals C, Sierra J (2007) Early clinical impact of iron overload in stem cell transplantation: a prospective study. Ann Hematol 86:443-447 (Pubitemid 46655483)
22. Azar N, Valla D, Abdel-Samad I, Hoang C, Fretz C, Sutton L, Fournel JJ, Le Charpentier Y, Binet JL, Leblond V (1996) Liver dysfunction in allogeneic bone marrow transplantation recipients. Transplantation 62:56-61
23. Maradei SC, Maiolino A, de Azevedo AM, Colares M, Bouzas LF, Nucci M (2009) Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 114:1270-1275
24. Morado M, Ojeda E, Garcia-Bustos J, Aguado MJ, Arrieta R, Quevedo E, Navas A, Hernandez-Navarro F (2000) BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study. Hematology 4:505-512 (Pubitemid 30217860)
25. Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A (2010) Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 95:476-484
26. Mahindra A, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Kalaycio M, Sweetenham J, Bolwell B, Copelan E (2009) Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation. Bone Marrow Transplant 44:767-768
27. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN (2006) Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:506-510 (Pubitemid 43964819)
28. Shirin Nash MD, Marconi S, Krystyna Sikorska MD, Rizwan Naeem MD, Nash G (2002) Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing. Am J Clin Pathol 118:73-81 (Pubitemid 34734255)
29. Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B et al (1997) Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 90:994-998 (Pubitemid 27314132)
30. Li CK, Lai DH, Shing MMK et al (2000) Early iron reduction programme for thalassaemia patients after bone marrow transplantation. Bone Marrow Transplant 25:653-656 (Pubitemid 30156591)
31. Cappellini MD (2008) Long-term efficacy and safety of deferasirox. Blood Rev 22(Suppl 2):35-41
32. Majhail NS, Lazarus HM, Burns LJ (2010) A prospective study of iron-overload management in allogeneic hematopoietic-cell transplant survivors. Biol Blood Marrow Transplant 16:832-837
33. Vichinsky E (2008) Clinical application of deferasirox: practical patient management. Am J Hematol 83:398-402 (Pubitemid 351614754)
34. Deeg HJ, Spaulding E, Shulman HM (2009) Iron overload, hematopoietic cell transplantation, and graft-versus-host disease. Leuk Lymphoma 50:1566-1572